Live feed16:30:00·51dPRReleasevia QuantisnowCVRx Announces First Patient Enrollment in BENEFIT-HF, a Landmark Heart Failure Trial Evaluating Barostim in Significantly Expanded PopulationByQuantisnow·Wall Street's wire, on your screen.CVRX· CVRx Inc.Health Care
